Innovative Therapies in Ophthalmology Can Save Sight

Innovative Therapies in Ophthalmology Can Save Sight Innovative therapies are vital for preventing permanent vision loss in patients with macular degeneration, allowing them to maintain their quality of life and work capacity. Ensuring timely access to these treatments requires stable financing mechanisms and continuous investment in new medications. The development of an Atlas of Macular Degeneration in the region aims to provide a comprehensive overview of diagnostics and treatments, identifying areas for improvement.

• Innovative therapies can significantly alter the course of macular degeneration, preserving vision and quality of life if applied promptly.
• There is a need for increased and consistent investment in the procurement of innovative medicines, which are continually emerging on the market.
• A stable and systemic financing mechanism is essential for expanding the list of available treatments.
• Preventive eye examinations and maintaining overall health, including managing blood pressure and sugar levels, are important for preserving sight.
• An Atlas of Macular Degeneration is being developed to consolidate data on diagnostics, therapies, and patient pathways across different countries in the region.
• Macular degeneration is a complex issue requiring long-term commitment, encompassing social, economic, and health-political aspects.